1,060,000
TB incidence in Indonesia in 2022
31,000
drug-resistant TB incidence in Philippines in 2022
13,600
deaths from TB in Vietnam in 2022
Members of The Union Asia Pacific Region
The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues.
The Union Asia Pacific Region is made up of close to 400 individuals and organisations.
Our work in Asia Pacific
The 10th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease (APRC 2026), took place from 4-7 February 2026 in at Bangkok. With the theme of “Transforming Lung Health and Creating a Future Free of Tuberculosis through Research, Innovation, and Networking”, the program included the fields of tuberculosis, emerging respiratory infectious disease, universal health coverage and environmental factors on communicable disease (especially tuberculosis) and non-communicable disease, including asthma, chronic obstructive pulmonary disease, lung cancer, and interstitial lung disease.
UNION NEWS FROM THE Asia pacific REGION
Can we optimize the TB response amid funding constraints using evidence-based, cost-effective strategies
An article in a forthcoming issue of IJTLD OPEN examines cost-effective and integrated strategies to sustain and strengthen the TB response in low- and middle-income countries amid declining donor funding.
Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatment
An article in a forthcoming issue of PHA assesses efforts to strengthen drug susceptibility testing in seven countries to support BPaL rollout, highlighting variable capacity and the need for ongoing training and infrastructure.
Financing the future of TB control: from dependence to resilience
An Editorial in a forthcoming issue of PHA highlights how cuts in donor funding for TB threaten progress but also present an opportunity for governments to invest in resilient, patient-centered health systems. The preprint is free to read.